|
FAM131A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.051600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.789200E-01 |
| Normal-vs-Stage2 |
3.448400E-02 |
| Normal-vs-Stage3 |
3.225400E-01 |
| Normal-vs-Stage4 |
8.168800E-01 |
| Stage1-vs-Stage2 |
7.577600E-03 |
| Stage1-vs-Stage3 |
2.471200E-01 |
| Stage1-vs-Stage4 |
9.928600E-01 |
| Stage2-vs-Stage3 |
1.102820E-01 |
| Stage2-vs-Stage4 |
2.689700E-02 |
| Stage3-vs-Stage4 |
4.280400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.016600E-01 |
| Normal-vs-AfricanAmerican |
5.388000E-01 |
| Normal-vs-Asian |
5.281600E-01 |
| Caucasian-vs-AfricanAmerican |
5.311800E-01 |
| Caucasian-vs-Asian |
2.286400E-01 |
| AfricanAmerican-vs-Asian |
1.703200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.164200E-01 |
| Normal-vs-Female |
5.452000E-01 |
| Male-vs-Female |
7.181200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.911400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.258800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.560300E-02 |
| Normal-vs-Age(81-100Yrs) |
8.512600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.823600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.999440E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.206800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.892100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.187400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.148600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.298100E-02 |
| Classical-VS-Follicular |
1.62447832963153E-12 |
| Classical-VS-Other |
6.333200E-01 |
| Classical-VS-Normal |
5.587000E-01 |
| Tall-VS-Follicular |
3.643800E-04 |
| Tall-VS-Other |
1.090750E-01 |
| Tall-VS-Normal |
3.234400E-01 |
| Follicular-VS-Other |
3.605300E-04 |
| Follicular-VS-Normal |
1.222010E-04 |
| Other-VS-Normal |
5.588600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.802300E-02 |
| Normal-vs-N1 |
8.135400E-01 |
| N0-vs-N1 |
6.741500E-03 |
|
|
